Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.Financial_Report.xls
10-K - 2012 ANNUAL REPORT - Medical Information Technology, Inc.tenk.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R31.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R50.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R30.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R47.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R32.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R23.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R52.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R36.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R39.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R48.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R33.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R27.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R38.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R43.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R53.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R44.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R41.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R35.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R51.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R24.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R34.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R37.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R28.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R45.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R55.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R42.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R54.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R29.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R46.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R40.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R25.htm
XML - IDEA: XBRL DOCUMENT - Medical Information Technology, Inc.R49.htm
EX-32 - SECTION 1350 CERTIFICATIONS - Medical Information Technology, Inc.ex32.htm
EX-21 - SUBSIDIARIES OF THE COMPANY - Medical Information Technology, Inc.ex21.htm
EX-23 - CONSENT OF ERNST & YOUNG LLP - Medical Information Technology, Inc.ex23.htm
EX-31 - RULE 13A-14(A) CERTIFICATIONS - Medical Information Technology, Inc.ex31.htm
v2.4.0.6
Available For Sale Securities: (Tables)
12 Months Ended
Dec. 31, 2012
Available For Sale Securities:
Note 2. Available For Sale Securities:

MEDITECH follows the provisions of ASC 320-10, Investments - Debt and Equity Securities, which requires marketable securities be classified as trading, available-for-sale or held-to-maturity. MEDITECH classifies its marketable securities as available-for-sale and records them at fair value with any unrealized gains or losses, net of tax, reported as a component of shareholder equity. The fair value was determined based on quoted prices in active markets. ASC 320-10 requires that for each individual security classified as available-for-sale, a company shall determine whether a decline in fair value below the cost basis is temporary in nature. If the decline in fair value is not judged as such, the cost basis of the individual security shall be reduced to fair value and the amount of the write-down shall be reflected in earnings.

MEDITECH follows the provisions of ASC 320-10-35 Subsequent Measurement, and evaluates its marketable securities for other-than-temporary impairment using an impairment model consistent with a debt security. The factors considered include the severity and duration of the loss, the intent and ability to hold the securities for an extended period of time until recovery, and whether issuers are current on dividend payments and maintain investment grade ratings. Finally, the effect of fluctuating interest rates, current economic and industry conditions, and the issuers’ current financial position are also taken into consideration.

MEDITECH follows the provisions of ASC 820-10, Fair Value Measurements and Disclosures, which provides for expanded disclosure and guidelines to determine fair market value of assets and liabilities. ASC 820-10 applies whenever other standards require or permit assets and liabilities to be measured at fair value, but does not expand the use of fair value in any new circumstances. MEDITECH’s marketable securities represent assets measured at fair value on a recurring basis, and are considered Level 1 assets as defined by ASC 820-10.

The unrealized gains and the unrealized losses have been accounted for within comprehensive income. The following table indicates the cost net of write-downs, unrealized gains, unrealized losses and fair market value of MEDITECH’s securities for the three years ended December 31. MEDITECH has evaluated the unrealized losses as of December 31, 2012 and has concluded that the unrealized losses are temporary in nature.

 201020112012
 


Net cost of equities$160,353,893$231,177,996$272,879,085
Unrealized gains28,744,26647,060,29558,012,812
Unrealized losses(210,115)(883,522)(1,236,625)
 


Fair market value$188,888,044$277,354,769$329,655,272